Sato M - Search Results

1

Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.

Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M. Fisher JE, et al. Among authors: sato m. Endocrinology. 1993 Mar;132(3):1411-3. doi: 10.1210/endo.132.3.8440195. Endocrinology. 1993. PMID: 8440195

2

Echistatin is a potent inhibitor of bone resorption in culture.

Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ. Sato M, et al. J Cell Biol. 1990 Oct;111(4):1713-23. doi: 10.1083/jcb.111.4.1713. J Cell Biol. 1990. PMID: 2211834 Free PMC article.

3

The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures.

Shinar DM, Sato M, Rodan GA. Shinar DM, et al. Among authors: sato m. Endocrinology. 1990 Mar;126(3):1728-35. doi: 10.1210/endo-126-3-1728. Endocrinology. 1990. PMID: 2407522

4

Structure-activity studies of the s-echistatin inhibition of bone resorption.

Sato M, Garsky V, Majeska RJ, Einhorn TA, Murray J, Tashjian AH Jr, Gould RJ. Sato M, et al. J Bone Miner Res. 1994 Sep;9(9):1441-9. doi: 10.1002/jbmr.5650090917. J Bone Miner Res. 1994. PMID: 7817829

5

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA. Sato M, et al. J Clin Invest. 1991 Dec;88(6):2095-105. doi: 10.1172/JCI115539. J Clin Invest. 1991. PMID: 1661297 Free PMC article.

6

Bone acidic glycoprotein 75 inhibits resorption activity of isolated rat and chicken osteoclasts.

Sato M, Grasser W, Harm S, Fullenkamp C, Gorski JP. Sato M, et al. FASEB J. 1992 Aug;6(11):2966-76. doi: 10.1096/fasebj.6.11.1644260. FASEB J. 1992. PMID: 1644260

7

Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance.

Yang NN, Bryant HU, Hardikar S, Sato M, Galvin RJ, Glasebrook AL, Termine JD. Yang NN, et al. Among authors: sato m. Endocrinology. 1996 May;137(5):2075-84. doi: 10.1210/endo.137.5.8612550. Endocrinology. 1996. PMID: 8612550

8

Myosin II antibodies inhibit the resorption activity of isolated rat osteoclasts.

Sato M, Grasser W. Sato M, et al. Cell Motil Cytoskeleton. 1990;17(3):250-63. doi: 10.1002/cm.970170311. Cell Motil Cytoskeleton. 1990. PMID: 2268876

9

Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.

Sato M, Zeng GQ, Turner CH. Sato M, et al. Endocrinology. 1997 Oct;138(10):4330-7. doi: 10.1210/endo.138.10.5440. Endocrinology. 1997. PMID: 9322947

10

New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.

Ma YL, Bryant HU, Zeng Q, Schmidt A, Hoover J, Cole HW, Yao W, Jee WS, Sato M. Ma YL, et al. Among authors: sato m. Endocrinology. 2003 May;144(5):2008-15. doi: 10.1210/en.2002-221061. Endocrinology. 2003. PMID: 12697709

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,206 results

Search Page

Filters